Searched for
CHINA ASTRAZENECA
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- AstraZeneca signs AI research deal with China's CSPC for chronic diseasesUnder Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule or...
- China detains AstraZeneca staff in data, drug-import probes: Report"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...
- China probing AstraZeneca employees for potential illegal actsAstraZeneca has confirmed that several of its employees in China are under investigation for potential illegal data collection and unapprov...
- AstraZeneca to buy China's Gracell Bio for up to $1.2 billionThe cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per AD...
- Hong Kong govt to delay imports of AstraZeneca vaccine amid safety concernsHealth Secretary Sophia Chan said the global financial centre had a sufficient supply of vaccines, with a total of 15 million doses of Germ...
- AstraZeneca woes grow as Australia, Philippines, African Union curb COVID-19 shotsThe vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concern...
- Philippines to temporarily suspend use of AstraZeneca Covid-19 vaccine for people below 60 yearsThe European Medicines Agency on Wednesday reported a possible link but did not recommend any age restrictions on using the drug in adults....
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...
- WHO reviewing data, recommends AstraZeneca Covid jabs continue"The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data," the UN health agency said in...
- WHO experts to meet over AstraZeneca vaccine blood clot fears as coronavirus cases surgeThe World Health Organization, AstraZeneca, and the European Medicines Agency have insisted the shot is safe, and that there is no link bet...
- Britain approves AstraZeneca/Oxford COVID-19 vaccineRegulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the resul...
- AstraZeneca sells cholesterol drug rights to Grünenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
- When and which COVID-19 vaccines are likely to be available in AsiaTrial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in...
- When and which COVID-19 vaccines are likely to be available in AsiaThe head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov 23 the positive late-state trial result of the c...
- AstraZeneca in first COVID-19 vaccine deal with Chinese companyThe deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...
- Sun Pharma rallies 4% on pact to launch cancer drugs in ChinaThe agreement will help bring cost effective and quality drugs to patients in China.
- AstraZeneca to axe 1,400 jobs in Europe, shuts three plantsAnglo-Swedish pharmaceuticals giant AstraZeneca said that it would slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Swe...
- AstraZeneca to get drugs made in IndiaAstraZeneca, Britain’s second largest pharmaceutical company, is planning to outsource all its drug manufacturing activities to India and o...
Load More
